Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Etablissements Delhaize Freres (DEG)

Etablissements Delhaize Freres (DEG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
De Grey Reaches A$7M Minimum Spend at Egina Gold Project and Continues Investment GlobeNewswire - Wed Oct 9, 10:39AM CDT

NVO-WT.TO : 0.01 (unch)
NSRPF : 0.0654 (-4.53%)
NVO.AX : 0.100 (-13.04%)
NVO : 111.94 (-0.01%)
DEG : 28.11 (-0.07%)
NVO.TO : 0.0900 (unch)
Exploration Program Update Globe NewsWire - Thu Jun 3, 2021

VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Novo Resources Corp. ( “Novo” or the “Company” ) (TSX: NVO & NVO.WT; OTCQX: NSRPF) is pleased to provide an update on its current...

NVO.TO : 0.0900 (unch)
NVO-WT.TO : 0.01 (unch)
NSRPF : 0.0654 (-4.53%)
KZR.AX : 0.092 (unch)
GBZ.AX : 0.009 (unch)
DEG.AX : 1.480 (-2.95%)
CAI.AX : 0.115 (+9.52%)
DEG : 28.11 (-0.07%)
CAI : 56.00 (+0.02%)
KZR : 7.21 (-3.22%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot